Where it comes from
Synthesized in 1876 as a textile dye, methylene blue was soon used as a stain in laboratories and then as an early antimalarial – arguably the first fully synthetic drug used in medicine. Its medical identity today is much narrower than its history suggests.
What it is actually approved for
In the US, methylene blue injection is FDA-approved to treat acquired methemoglobinemia – a condition where hemoglobin cannot release oxygen properly. That is a hospital-level indication with a specific dose, given by clinicians. It is not approved for energy, focus, mood, or longevity.
Why the internet is interested
In the laboratory, methylene blue can act as an electron carrier in the mitochondrial respiratory chain, and animal work has explored effects on brain energy metabolism. That mechanism is genuinely interesting – and genuinely preliminary. Interesting mechanism is not the same as demonstrated human benefit.
The safety part people skip
Methylene blue inhibits monoamine oxidase, so combining it with SSRIs, SNRIs, or other serotonergic medications carries a real risk of serotonin toxicity. It can also cause problems in people with G6PD deficiency. This is exactly why it belongs in a clinician conversation and not a shopping cart.
Common questions
Is methylene blue FDA approved?
The injectable prescription form is FDA-approved for acquired methemoglobinemia. Products marketed for energy, cognition, or longevity are not FDA-approved for those uses.
Is 'pharmaceutical grade' the same as safe?
Purity and appropriateness are different questions. Industrial or aquarium-grade methylene blue is not intended for human use at all, and even pharmaceutical-grade product carries interaction risks a clinician must screen for.
Can I take it with my antidepressant?
This is a serious interaction question - methylene blue's MAO inhibition can combine dangerously with serotonergic medications. Ask a clinician before combining anything.